Log In
Print
BCIQ
Print
Print this Print this
 

Suboxone, buprenorphine/naloxone

  Manage Alerts
Collapse Summary General Information
Company Indivior plc
DescriptionBuprenorphine and naloxone tablet
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationAddiction
Indication DetailsTreat opiate dependency
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today